- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03874403
Anesthetic Component Research on VATS and NIVATS
October 6, 2020 updated by: National Taiwan University Hospital
Advanced Research on the Anesthetic Component and Monitor During the Nonintubated Video-assisted Thoracoscopic Surgery (NIVATS)
The non-intubated video-assisted thoracic surgery (NIVATS) can avoid intubation-related complications and for a smoother postoperative recovery.
Successful results are accumulating not only from anecdotal case reports of difficult and high-risk patients not suitable for an intubated general anesthesia.
However, in spite of safety and feasibility, there were still three main concerns: 1. how to maintain spontaneous breathing with optimal anesthetic depth; 2. How to analyze the components of general anesthesia and regional anesthesia; 3.what's the benefits on the recovery and the risk of aspiration risk with NIVATS?
The traditional monitor or methods such as BIS system, SpO2, and follow-up aspiration signs could not offer sufficient evidence to resolve the three main concerns.
Recently, there have been many new methods to monitor these concerns.
The density spectral array (DSA) BIS system could analyze the change of the anesthetic component.
The ORI is a dimensionless index that reflects oxygenation in the moderate hyperoxic range (PaO2 100-200 mmHg).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Background: The non-intubated video-assisted thoracic surgery (NIVATS) can avoid intubation-related complications and for a smoother postoperative recovery.
In recent years, investigator have completed more than 1000 NIVATS.
However, the benefits on recovery including swallowing and esophageal function have nerver been demonstrated.
The anesthetic components include an intravenous general anesthesia with an intraoperative nerve blocks.
Monitoring and analyzing the components of anesthesia have rarely been studied.
In this study, the investigator plan to do a radomized control study to demonstarte the differences between NIVATS and intubated VATS, and to investigate the differences on recovery and anesthetic components.
Patients schedured for VATS operation, suitable for NIVATS will be included and randomized into NIVATS or VATS groups.
DSA and Ce will be monitored throughout the surgical procedures.
swalowing test, esophageal function and postoperative qustionare for food intake will be recorded, collected and analyzed.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients schedured for VATS operations, suitable for NIVATS after anesthetic evaluation
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NIVATS
Patients receiving Non-intubated VATS with DSA changes
|
The changes on DSA on NIVATS and VATS
|
Other: Intubated VATS
Patients receiving intubated VATS with DSA changes
|
The changes on DSA on NIVATS and VATS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The changes of Ce of propofol and remifentanil
Time Frame: four hours in the intraoperative period
|
The changes of concentration of effective site (Ce) shown on TCI pump before and after intercostal nerve block in NIVATS and VATS groups
|
four hours in the intraoperative period
|
density spectral array changes with thoracoscopic intercostal nerve blocks
Time Frame: four hours in the intraoperative period
|
a colour display that represents the frequencies and amplitudes of brain waves through time, with the colour spectrum ranging from blue (minimum amplitude) to dark red (maximum amplitude).
|
four hours in the intraoperative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: ya-jung Cheng, Department of Anesthesiology, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2018
Primary Completion (Actual)
October 2, 2019
Study Completion (Actual)
September 30, 2020
Study Registration Dates
First Submitted
February 28, 2019
First Submitted That Met QC Criteria
March 12, 2019
First Posted (Actual)
March 14, 2019
Study Record Updates
Last Update Posted (Actual)
October 8, 2020
Last Update Submitted That Met QC Criteria
October 6, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 201712125RINB
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracoscopy
-
Tri-Service General HospitalNot yet recruitingAnalgesia | Dexmedetomidine | Thoracoscopy
-
University Hospital, RouenCompletedAnesthesia | Video Assisted ThoracoscopyFrance
-
Rennes University HospitalCompleted
-
Mansoura UniversityRecruiting
-
University Hospital, Clermont-FerrandTerminatedThoracotomy | ThoracoscopyFrance
-
Postgraduate Institute of Medical Education and...Active, not recruitingMedical ThoracoscopyIndia
-
Assiut UniversityCompletedThoracoscopy | PrehabilitationEgypt
-
Dr Cipto Mangunkusumo General HospitalSingapore General HospitalRecruitingMedical ThoracoscopyIndonesia
-
National Taiwan University HospitalRecruiting
-
University Hospital Inselspital, BerneUnknown
Clinical Trials on DSA
-
University Hospital, BrestUnknown
-
Wuhan General Hospital of Guangzhou Military CommandCompleted
-
Kyungpook National University HospitalCompletedDiagnostic ImagingKorea, Republic of
-
National Taiwan University HospitalUnknown
-
First People's Hospital of HangzhouRecruitingCoronary Artery Disease | Coronary Microvascular DiseaseChina
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandRecruitingIntracerebral Hemorrhage | Nontraumatic Intracerebral HemorrhageSwitzerland
-
Istituto Ortopedico GaleazziCompleted
-
the Jeunes en Neuroradiologie Interventionnelle...University Hospital, Limoges; Sainte Anne Hospital (Paris)Not yet recruitingEndocarditis, Bacterial | Aneurysm, Intracranial Mycotic
-
Chinese University of Hong KongRecruitingIschemic Stroke | Atheroscleroses, CerebralHong Kong
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Janssen Research & Development, LLCNot yet recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Myelofibrosis | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Hematologic Malignancy | Aplastic Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Bone Marrow Transplant Rejection | Acute Lymphoblastic Leukemia (ALL), Adult